This observation is novel in the context of depression and complements findings from other clinical conditions.27, 28, 30, 77 In addition, CBT-E reduced levels of CRP among those patients with potentially elevated cardiovascular risk (CRP⩾1 μg ml−1), confirming data from previous exercise trials.26, 27, 29, 76. The gene discussed is CRP; the disease is depressive disorder.